In 2024, a Harvard study found that the drugs were also linked to an increased risk of sudden and irreversible vision loss and blindness
However, this area hasnt been extensively studied, so discussing your specific situation with a provider makes sense
Their ability to promote gut healing, modulate inflammation, and support immune function makes them an excellent addition to any integrative treatment plan
Semaglutide is a GLP-1 agonist medication
A lower 4mg weekly dose also resulted in impressive weight loss results, with an average loss of 17% over 48 weeks and: 92% of participants lost at least 5% of their starting body weight 75% lost at least 10% of their body weight 60% lost at least 15% of their starting weight Retatrutide vs Mounjaro In clinical trials, the active ingredient in Mounjaro, tirzepatide, results in an average weight loss of 22.5% at the highest 15mg per week dose over 72 weeks
Not recommended for international shipping